Biosimilar

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

A product approved or on track for approval through abbreviated approval pathways in the U.S., Europe and other countries, based largely on similarities and comparisons with an already-approved reference biologic product.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters